World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
49
Citations
9113
World Ranking
4337
National Ranking
171

Marco W.J. Schreurs publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Marco W.J. Schreurs sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 188 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Marco W.J. Schreurs D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Marco W.J. Schreurs sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 49 D-Index — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Marco W.J. Schreurs is affiliated with Erasmus University Rotterdam in the Netherlands. Their research contributions are primarily in the field of Medicine, with a particular focus on Neurology, Rheumatology, Immunology and Allergy, Immunology, and Infectious Diseases.

The scientist's recent publications include studies across various topics in neurology, immunology, and infectious diseases. Notable papers are:

  • Neurologic syndromes related to anti-GAD65, 2020, published in Neurology Neuroimmunology & Neuroinflammation
  • Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection, 2021, Nature Communications
  • First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial, 2020, Gut
  • Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients, 2020, Thyroid
  • Pediatric autoimmune encephalitis, 2020, Neurology Neuroimmunology & Neuroinflammation

Their frequent co-authors include:

  • Maarten J. Titulaer
  • Juna M. de Vries
  • Josianne C. ten Berge
  • Anna E.M. Bastiaansen
  • Daphne P. C. Vergouwen

Most publications by Schreurs appear in specialized venues such as:

  • Neurology Neuroimmunology & Neuroinflammation
  • Nutrients
  • Neurology
  • Journal of Autoimmunity
  • Clinical Chemistry and Laboratory Medicine (CCLM)

The main topics of their research include:

  • Autoimmune Neurological Disorders and Treatments
  • Systemic Lupus Erythematosus Research
  • Peripheral Neuropathies and Disorders
  • Food Allergy and Anaphylaxis Research
  • Allergic Rhinitis and Sensitization
  • Ocular Diseases and Behçet's Syndrome
  • Genetics and Neurodevelopmental Disorders

Marco W.J. Schreurs has contributed extensively to scholarly work that intersects clinical neurology, immunological mechanisms, and systemic autoimmune conditions. Their research spans both fundamental and clinical applications, addressing pathologies from autoimmune encephalitis to systemic lupus erythematosus and allergic disorders.

Best Publications

  • Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

    A.B.H. Bakker;M.W.J. Schreurs;A.J. de Boer;Y. Kawakami

  • The clinical spectrum of Caspr2 antibody–associated disease

    Agnes van Sonderen;Helena Ariño;Mar Petit-Pedrol;Frank Leypoldt

  • The spectrum of celiac disease: epidemiology, clinical aspects and treatment

    Greetje J. Tack;Wieke H. M. Verbeek;Marco W. J. Schreurs;Chris J. J. Mulder

  • Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells

    Kirsten B.J. Scholten;Duco Kramer;Esther W.M. Kueter;Marcus Graf

  • Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies

    M. P. M. Adriaanse;G. J. Tack;V. Lima Passos;J. G. M. C. Damoiseaux

  • DPPX antibody–associated encephalitis: Main syndrome and antibody effects

    Makoto Hara;Helena Ariño;Mar Petit-Pedrol;Lidia Sabater

  • Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.

    Wieke H.M. Verbeek;Marije S. Goerres;B. Mary E. von Blomberg;Joost J. Oudejans

  • Identification of a novel peptide derived from the melanocyte‐specific gp100 antigen as the dominant epitope recognized by an HLA‐A2.1‐restricted anti‐melanoma CTL line

    A. B H Bakker;M. W J Schreurs;G. Tafazzul;A. J. De Boer

  • Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment.

    Amaia Muñoz-Lopetegi;Marienke A.A.M. de Bruijn;Sanae Boukhrissi;Anna E.M. Bastiaansen

  • The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies

    Agnes van Sonderen;Marco W.J. Schreurs;Marienke A.A.M. de Bruijn;Sanae Boukhrissi

  • The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.

    Paul J Hensbergen;Pepijn G J T B Wijnands;Marco W J Schreurs;Rik J Scheper

  • Anti‐LGI1 encephalitis is strongly associated with HLA‐DR7 and HLA‐DRB4

    Agnes van Sonderen;Dave L. Roelen;Johannes A. Stoop;Robert M. Verdijk

  • Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection.

    Arvind Gharbharan;Carlijn C E Jordans;Corine GeurtsvanKessel;Jan G den Hollander

  • From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time

    A. van Sonderen;M.W.J. Schreurs;P.W. Wirtz;P.A.E. Sillevis Smitt

  • Generation and functional characterization of mouse monocyte-derived dendritic cells.

    M.W.J. Schreurs;A.A.O. Eggert;A.J. de Boer;C.G. Figdor

  • Systemic interferon type I and type II signatures in primary Sjögren's syndrome reveal differences in biological disease activity

    Iris L A Bodewes;Shereen Al-Ali;Shereen Al-Ali;Cornelia G van Helden-Meeuwsen;Naomi I Maria

  • Intraocular cytokine profile and autoimmune reactions in retinitis pigmentosa, age-related macular degeneration, glaucoma and cataract.

    Josianne C. ten Berge;Zainab Fazil;L. Ingeborgh van den Born;Roger C. W. Wolfs

  • The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies.

    Marleen H van Coevorden-Hameete;Marleen H van Coevorden-Hameete;Marienke A A M de Bruijn;Esther de Graaff;Danielle A E M Bastiaansen

  • Evaluation of Cladribine treatment in refractory celiac disease type II

    Greetje J Tack;Wieke H M Verbeek;Abdul Al-Toma;Dirk J Kuik

  • Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy

    G J Tack;M J Wondergem;A Al-Toma;W H M Verbeek

Frequent Co-Authors

Chris J. J. Mulder
Chris J. J. Mulder Amsterdam UMC
Chris J.L.M. Meijer
Chris J.L.M. Meijer Vrije Universiteit Amsterdam
B. Mary E. von Blomberg
B. Mary E. von Blomberg VU University Medical Center
Ron H.J. Mathijssen
Ron H.J. Mathijssen Erasmus University Rotterdam
Michael T. Nurmohamed
Michael T. Nurmohamed University of Amsterdam
Roland D. Thijs
Roland D. Thijs Leiden University
Menno C. van Zelm
Menno C. van Zelm Monash University
Rik J. Scheper
Rik J. Scheper Amsterdam University Medical Centers
Dörte Hamann
Dörte Hamann University Medical Center Utrecht
Otto Visser
Otto Visser VU University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their career in immunology through nursing, several online programs offer flexible pathways. Many professionals transition into specialized roles by enrolling in acute care nurse practitioner programs, which provide focused training for managing complex patient care cases often linked to immune system disorders.

Accelerated study options are also popular among students seeking to enter the nursing field quickly. Programs like the accelerated nurse practitioner programs allow qualified candidates to fast-track their education, enabling them to step into advanced practice roles sooner.

For individuals without a nursing background, 12-month accelerated nursing programs online for non nurses offer a streamlined route to obtain nursing credentials. These programs are designed to build foundational knowledge quickly, which can be essential for those pivoting to healthcare careers involving immunology.

Additionally, those looking for more accessible entry points may consider easiest accelerated nursing programs, which often feature flexible admissions criteria and shorter completion times, making them ideal for busy learners or career changers.

Best Scientists Citing Marco W.J. Schreurs

Trending Scientists

Recently Published Articles